BRPI0510946A - tratamento de asma em crianças - Google Patents

tratamento de asma em crianças

Info

Publication number
BRPI0510946A
BRPI0510946A BRPI0510946-9A BRPI0510946A BRPI0510946A BR PI0510946 A BRPI0510946 A BR PI0510946A BR PI0510946 A BRPI0510946 A BR PI0510946A BR PI0510946 A BRPI0510946 A BR PI0510946A
Authority
BR
Brazil
Prior art keywords
children
asthma treatment
asthma
treatment
glycopyrrolate
Prior art date
Application number
BRPI0510946-9A
Other languages
English (en)
Inventor
Susan Snape
Robin Mark Bannister
Original Assignee
Sosei R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd
Publication of BRPI0510946A publication Critical patent/BRPI0510946A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

TRATAMENTO DE ASMAS EM CRIANçAS O glicopirrolato ou um análogo dele é útil no tratamento da asma em crianças.
BRPI0510946-9A 2004-05-10 2005-05-10 tratamento de asma em crianças BRPI0510946A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0410399.0A GB0410399D0 (en) 2004-05-10 2004-05-10 The treatment of respiratory disease
PCT/GB2005/001791 WO2005107873A2 (en) 2004-05-10 2005-05-10 Glycopyrrolate for treating childhood asthma

Publications (1)

Publication Number Publication Date
BRPI0510946A true BRPI0510946A (pt) 2007-11-20

Family

ID=32526760

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0510946-9A BRPI0510946A (pt) 2004-05-10 2005-05-10 tratamento de asma em crianças

Country Status (15)

Country Link
US (1) US20070243260A1 (pt)
EP (1) EP1750807A2 (pt)
JP (1) JP2007536362A (pt)
KR (1) KR20070042917A (pt)
CN (1) CN1972730A (pt)
AU (1) AU2005240406A1 (pt)
BR (1) BRPI0510946A (pt)
CA (1) CA2565170A1 (pt)
GB (1) GB0410399D0 (pt)
IL (1) IL178816A0 (pt)
MX (1) MXPA06013040A (pt)
NO (1) NO20065536L (pt)
NZ (1) NZ550909A (pt)
WO (1) WO2005107873A2 (pt)
ZA (1) ZA200610264B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
GB0410398D0 (en) * 2004-05-10 2004-06-16 Arakis Ltd The treatment of respiratory disease
GB0425758D0 (en) 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0613161D0 (en) 2006-06-30 2006-08-09 Novartis Ag Organic Compounds
CN102573912B (zh) * 2009-09-30 2014-01-01 三仪股份有限公司 难溶性物质的水溶性改善方法
GB0918150D0 (en) * 2009-10-16 2009-12-02 Jagotec Ag Improved formulations
BR112012015334A2 (pt) 2009-12-23 2016-03-15 Chiesi Farma Spa terapia combinada para doença pulmonar obstrutiva crônica
UA106098C2 (uk) 2009-12-23 2014-07-25 К'Єзі Фармачеутічі С.П.А. Аерозольна композиція для хозл
CN102695496B (zh) 2009-12-23 2014-10-01 奇斯药制品公司 用于copd的气雾剂制剂
CA2785321C (en) 2009-12-23 2018-08-21 Chiesi Farmaceutici S.P.A. Combination therapy for copd
JO3510B1 (ar) 2011-03-04 2020-07-05 Heptares Therapeutics Ltd استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
JP5909796B2 (ja) 2012-03-02 2016-04-27 株式会社サンギ 難溶性物質の水溶解性改善方法
JP6013450B2 (ja) * 2012-03-14 2016-10-25 株式会社Ｌｔｔバイオファーマ 慢性閉塞性肺疾患改善剤
WO2014062143A2 (en) * 2012-10-19 2014-04-24 Mahmut Bilgic Anticholinergic agent combinations
WO2014077787A1 (en) * 2012-11-16 2014-05-22 Mahmut Bilgic Combinations including abeta2 agonist and glycopyrrolate
HUE039513T2 (hu) 2013-12-30 2019-01-28 Chiesi Farm Spa Glikopirrónium-bromid és formoterol kombinációját tartalmazó nyomás alatti stabil aeroszol oldatkészítmény
NZ728435A (en) * 2014-09-09 2017-11-24 Vectura Ltd Formulation comprising glycopyrrolate, method and apparatus
HRP20200571T1 (hr) * 2015-11-16 2020-07-10 Chiesi Farmaceutici S.P.A. Postupak priprave formulacije suhog praška koji sadrži antikolinergik, kortikosteroid i beta-adrenergik
US10098837B2 (en) 2016-07-28 2018-10-16 Chiesi Farmaceutici S.P.A. Combination therapy for COPD
PE20221439A1 (es) 2019-12-02 2022-09-21 Chiesi Farm Spa Lata de acero inoxidable para inhaladores dosificadores presurizados

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1131059B1 (de) * 1998-11-13 2003-03-05 Jago Research Ag Trockenpulver zur inhalation
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
NZ526059A (en) * 2000-11-30 2005-05-27 Vectura Ltd Method of making composite active particles in the presence of an additive material for use in a pharmaceutical composition

Also Published As

Publication number Publication date
GB0410399D0 (en) 2004-06-16
US20070243260A1 (en) 2007-10-18
WO2005107873A2 (en) 2005-11-17
ZA200610264B (en) 2008-06-25
AU2005240406A1 (en) 2005-11-17
JP2007536362A (ja) 2007-12-13
CA2565170A1 (en) 2005-11-17
NO20065536L (no) 2006-12-08
KR20070042917A (ko) 2007-04-24
MXPA06013040A (es) 2007-02-12
IL178816A0 (en) 2007-05-15
EP1750807A2 (en) 2007-02-14
CN1972730A (zh) 2007-05-30
WO2005107873A3 (en) 2006-03-16
NZ550909A (en) 2011-02-25

Similar Documents

Publication Publication Date Title
BRPI0510946A (pt) tratamento de asma em crianças
NL301145I2 (nl) Tirbanibulin
BRPI0312331A2 (pt) composições de ácido hialurônico e métodos de emprego.
UA94221C2 (en) Lipocalin protein
IL187343A0 (en) Compositions and methods for the diagnosis and treatment of tumor
AT9566U3 (de) Kopierfräseinrichtung zur herstellung von zahntechnischen werkstücken
EP1567101A4 (en) PROPHYLACTIC TREATMENT METHODS
WO2003088808A3 (en) Compositions and methods for the diagnosis and treatment of tumor
MA28985B1 (fr) Analogues de loxapine et methodes d'utilisation
BRPI0510947A (pt) tratamento de doença respiratória
NO20071378L (no) Tiazolo-naftylsyrer.
DK1560812T3 (da) Aminocyclohexyletherforbindelser og anvendelser deraf
IL163026A (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
TW200630367A (en) Substituted adenines and the uses thereof
EP1976548A4 (en) VIP FRAGMENTS AND APPLICATION PROCEDURES
WO2004024063A3 (en) Compositions and methods for the diagnosis and treatment of tumor
IS7166A (is) Notkun annellataðra pýrrólsambanda í meðhöndlun áliðabrjósks- eða neðanbrjósksbeinahrörnun
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
DE602005015297D1 (de) Verwendung von ozon zur verbesserung des knetvorgangs
GB2393571B (en) Improvements in and relating to the control of instruments
ZA200706662B (en) Haloaryl substituted Aminopurines, compositions thereof, and methods of treatment therewith
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
NO20053903D0 (no) Nukleotidlipidesterderivater.
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon
WO2007022321A3 (en) Substituted indoles and use thereof

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2204 DE 02/04/2013.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/00 (2006.01), A61P 11/06 (2006.01), A61K 3